Intermediate-day plants (IDP) flower most rapidly and completely under intermediate photoperiods (e.g., 12-14 h of light), but few species have been identified and their flowering responses are not well understood. We identified Echinacea purpurea Moench as an IDP and, based on our results, propose a novel mechanism for flowering of IDP. Two genotypes of E. purpurea ('Bravado' and 'Magnus') flowered most completely (>/=79%) and rapidly and at the youngest physiological age under intermediate photoperiods of 13-15 h. Few (/=230% as the photoperiod or NI duration increased, until plants received a saturating duration (at 14 or 1 h, respectively). Flowering was inhibited when 16-h photoperiods were deficient in red (R, 600-700 nm) light, and was promoted when photoperiods were deficient in far-red (FR, 700-800 nm) light. Because of our results, we propose the flowering behavior of IDP such as E. purpurea is composed of two mechanisms: a light-dependent response operating through light-labile (type I) phytochrome in which flowering is inhibited by an LD, and a light-stable (type II) phytochrome (i.e., phyB, D and E) response in which flowering is promoted by a short-night.

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1399-3054.2001.1120318.xDOI Listing

Publication Analysis

Top Keywords

echinacea purpurea
8
intermediate photoperiods
8
flowering inhibited
8
photoperiods deficient
8
type phytochrome
8
flowering
6
photocontrol flowering
4
flowering stem
4
stem extension
4
extension intermediate-day
4

Similar Publications

Upper respiratory tract infections (URTIs) are a prevalent health issue, causing considerable morbidity. Despite the availability of conventional treatments, there is an increasing interest in natural products due to their potential antiviral and immunomodulatory benefits. This study aims to evaluate the efficacy of an ELA blend (E-, L-, A-) in preventing and alleviating the symptoms of URTIs.

View Article and Find Full Text PDF
Article Synopsis
  • A study aimed to investigate the effects of Echinacea extract syrup on COVID-19 patients’ respiratory outcomes, given its known antiviral properties, despite limited evidence for its effectiveness against the virus.
  • The research involved a single-blind randomized controlled trial with 40 hospitalized COVID-19 patients split into two groups; one received Echinacea syrup in addition to standard treatment, while the other received standard treatment only.
  • Results showed a significant decrease in white blood cell counts in the group receiving Echinacea, but no significant differences in arterial oxygen pressure or lung involvement between the two groups after treatment.
View Article and Find Full Text PDF

This study aimed to discover how Echinacea powder extract (EPE), an antioxidant, affects the growth rate, body composition, and blood parameters in broilers as an alternative to antibiotics. In a completely randomized design study, 4 experimental groups received 280 broiler chicks, 5-days-old (Cobb 500). Each group was distributed into 7 replicates, each containing ten unsexed chicks.

View Article and Find Full Text PDF

and Combined Extracts Cause Immunomodulatory Effects in Lipopolysaccharide-Challenged Rats.

Plants (Basel)

December 2024

Department of Bioorganic Chemistry, Faculty of Pharmacy, Medical University of Plovdiv, 15A Vassil Aprilov Blvd., 4002 Plovdiv, Bulgaria.

and which belong to the Asteraceae family, are widely used plants in traditional medicine. Their antioxidant, anti-inflammatory, antiviral, antibacterial, and antitumor effects are well known. However, there are no data on the effects of their combination.

View Article and Find Full Text PDF

Unlabelled: (L.), a member of family, has traditionally been used in numerous countries to treat and prevent various immune-related diseases. This study confirmed the oral toxicity and genotoxicity profile of standardized extract under good laboratory practice (GLP) conditions and the pharmacokinetic features of chicoric acid, a major ingredient in extract.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!